CFO
CL icon

Callan Family Office’s Colgate-Palmolive CL Stock Holding History

Callan Family Office’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
13,908
+2,978
+27% +$261K 0.02% 529
2026
Q1 		$932K Buy
10,930
+511
+5% +$45.5K 0.02% 581
2025
Q4 		$823K Sell
10,419
-1,283
-11% -$101K 0.02% 607
2025
Q3 		$935K Sell
11,702
-6,983
-37% -$596K 0.03% 396
2025
Q2 		$1.7M Buy
18,685
+13,848
+286% +$1.26M 0.05% 296
2025
Q1 		$453K Sell
4,837
-1,913
-28% -$171K 0.03% 346
2024
Q4 		$614K Buy
+6,750
New +$644K 0.04% 332

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Callan Family Office's CL Position: Q2 2026 in Review

Callan Family Office increased its Colgate-Palmolive (CL) stake by 27% in Q2 2026, buying an estimated $261K and bringing the position to 13,908 shares worth $1.28M. The position accounts for 0.02% of the portfolio, ranked #529.

Callan Family Office first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.7M in Q2 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Callan Family Office held 13,908 shares of Colgate-Palmolive worth $1.28M as of Q2 2026.
  • Callan Family Office bought 2,978 Colgate-Palmolive shares in Q2 2026, an estimated $261K.
  • Colgate-Palmolive made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #529 holding.
  • Callan Family Office first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Colgate-Palmolive position peaked at $1.7M in Q2 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.